E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/5/2014 in the Prospect News PIPE Daily.

ContraVir Pharmaceuticals completes $3.23 million placement of units

Six-year, half-share warrants are included in offering's equity units

By Devika Patel

Knoxville, Tenn., Feb. 5 - ContraVir Pharmaceuticals Inc. settled a $3.23 million private placement of units on Feb. 4, according to an 8-K filed Wednesday with the Securities and Exchange Commission.

The company sold 9,485,294 units of one common share and a half-share warrant at $0.34 per unit.

The whole warrants are each exercisable at $0.37 for six years.

The private biopharmaceutical company is based in New York.

Issuer:ContraVir Pharmaceuticals Inc.
Issue:Units of one common share and a half-share warrant
Amount:$3,225,000
Units:9,485,294
Price:$0.34
Warrants:One half-share warrant per unit
Warrant expiration:Six years
Warrant strike price:$0.37
Settlement date:Feb. 4

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.